April 27, 2009 – Medifacts International Inc. and Japanese cardiac safety service provider Suzuken Co. Ltd. have formed a strategic alliance to deliver advanced technology and centralized cardiac safety testing services to the biopharmaceutical and medical device industry in Japan.
Companies in Japan will now have access to cardiac safety monitoring technology and services for the management of their clinical trials.
The alliance will reportedly provide the most comprehensive and localized logistics, site support and data management in Asia for central electrocardiogram (ECG) and ambulatory blood pressure monitoring (ABPM) collection services. Operating from centers in Nagoya, Sapporo and Tokyo as well as two sites in Shanghai, China, the alliance will provide over 200 personnel – including a field support force of 130 equipment experts – from five shared facilities supporting cardiac safety studies across Asia.
For more information: www.medifacts.com_
January 29, 2020 
